At Altair Science Limited, we advance global health through innovative pharmaceutical solutions built on scientific excellence, ethical research, and an unwavering commitment to patient outcomes.
Driving new breakthroughs in healthcare innovation through disciplined, curiosity-led research that challenges current boundaries.
Every project is anchored to real people. We measure success by the meaningful difference our solutions make in patients' lives worldwide.
Delivering safe, effective, and life-changing pharmaceutical solutions that meet the highest standards at every stage of the pipeline.
Addressing some of the most pressing unmet medical needs of our time, from neglected diseases to next-generation treatment pathways.
Our Business Development team is the driving force behind strategic growth, partnerships, and innovation in the pharmaceutical sector.
Collaborating with research institutions, biotech firms, and healthcare providers to accelerate drug development and commercialisation.
Identifying new geographic and therapeutic markets, adapting products to meet local regulatory and patient needs.
Securing agreements and acquisition opportunities that strengthen our pipeline and product portfolio.
Evaluating and adopting cutting-edge technologies, formulations, and delivery systems to enhance patient outcomes.
Ensuring all partnerships and ventures meet the highest standards of global regulatory compliance.
Collaboration & Partnership Enquiries
admin@altairscience.co.ukAltair Science is actively seeking co-development agreements, in-licensing opportunities, and strategic joint ventures across therapeutic areas including oncology, rare disease, and specialty care.
Schedule a DiscussionWhether you're exploring a partnership, have a research enquiry, or simply want to learn more about our work — we'd love to hear from you.
Address
John Eccles House, Science Park,
Robert Robinson Ave, Littlemore,
Oxford OX4 4GP, UK